Clinical trials
Observational Angioedemas, Hereditary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 3 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Recruiting | 6 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 15 |
| Shire | 6 |
| University Hospital, Grenoble | 4 |
| CENTOGENE GmbH Rostock | 3 |
| Istituti Clinici Scientifici Maugeri SpA | 3 |
| CSL Behring | 2 |
| Pharming Technologies B.V. | 2 |
| Foundation For Rare Disease Research | 1 |
| HAE Global Registry Foundation | 1 |
| Hospital Italiano de Buenos Aires | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Angioedemas, Hereditary | 43 |
| Angioedema | 7 |
| Hereditary Angioedema Types I and II | 3 |
| Rare Diseases | 3 |
| Mastocytosis | 2 |
| Abdominal Pain | 1 |
| Adrenal Hyperplasia, Congenital | 1 |
| Amyloidosis | 1 |
| Anxiety Disorders | 1 |
| Cardiomyopathy, Hypertrophic | 1 |
Trials
Showing 51 to 43 of 43. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.